Fig. 4From: Combating drug resistance in acute myeloid leukaemia by drug rotations: the effects of quizartinib and pexidartinibCell counts and growth rates for cells treated with pexidartinib at IC90 (PE*). The growth rates (divisions per cell and day), were calculated at days 3 and 6 and are indicated on each line. a MOLM-14 cells, b MV4-11 cellsBack to article page